MOTT RICHARD W 4
4 · TREACE MEDICAL CONCEPTS, INC. · Filed May 13, 2024
Insider Transaction Report
Form 4
MOTT RICHARD W
Director
Transactions
- Purchase
Common Stock
2024-05-10$4.57/sh+83,198$379,849→ 990,951 total - Purchase
Common Stock
2024-05-13$4.38/sh+36,802$161,090→ 1,027,753 total
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $4.4000 to $4.6500 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.
- [F2]Includes 2,753 restricted stock units
- [F3]The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $4.320 to $4.5900 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.